{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:34:16Z","timestamp":1761676456643},"reference-count":32,"publisher":"Pharmaceutical Society of Japan","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2016]]},"DOI":"10.1248\/bpb.b16-00369","type":"journal-article","created":{"date-parts":[[2016,9,5]],"date-time":"2016-09-05T22:05:04Z","timestamp":1473113104000},"page":"1823-1829","source":"Crossref","is-referenced-by-count":16,"title":["Cholesterol-Lowering Effect of Octaarginine-Appended \u03b2-Cyclodextrin in &lt;i&gt;Npc1&lt;\/i&gt;-Trap-CHO Cells"],"prefix":"10.1248","volume":"39","author":[{"given":"Keiichi","family":"Motoyama","sequence":"first","affiliation":[{"name":"Graduate School of Pharmaceutical Sciences, Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rena","family":"Nishiyama","sequence":"additional","affiliation":[{"name":"Graduate School of Pharmaceutical Sciences, Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Maeda","sequence":"additional","affiliation":[{"name":"Graduate School of Pharmaceutical Sciences, Kumamoto University"},{"name":"Research Fellow of Japan Society for the Promotion of Science"},{"name":"Program for Leading Graduate Schools \u201cHIGO (Health life science: Interdisciplinary and Glocal Oriented) Program,\u201d Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taishi","family":"Higashi","sequence":"additional","affiliation":[{"name":"Graduate School of Pharmaceutical Sciences, Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimasa","family":"Kawaguchi","sequence":"additional","affiliation":[{"name":"Institute for Chemical Research, Kyoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiroh","family":"Futaki","sequence":"additional","affiliation":[{"name":"Institute for Chemical Research, Kyoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Ishitsuka","sequence":"additional","affiliation":[{"name":"Graduate School of Pharmaceutical Sciences, Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Kondo","sequence":"additional","affiliation":[{"name":"Graduate School of Pharmaceutical Sciences, Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsumi","family":"Irie","sequence":"additional","affiliation":[{"name":"Graduate School of Pharmaceutical Sciences, Kumamoto University"},{"name":"Program for Leading Graduate Schools \u201cHIGO (Health life science: Interdisciplinary and Glocal Oriented) Program,\u201d Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Era","sequence":"additional","affiliation":[{"name":"Department of Cell Modulation, Institute of Molecular Embryology and Genetics, Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetoshi","family":"Arima","sequence":"additional","affiliation":[{"name":"Graduate School of Pharmaceutical Sciences, Kumamoto University"},{"name":"Program for Leading Graduate Schools \u201cHIGO (Health life science: Interdisciplinary and Glocal Oriented) Program,\u201d Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Carstea ED, Morris JA, Coleman KG, Loftus SK, Zhang D, Cummings C, Gu J, Rosenfeld MA, Pavan WJ, Krizman DB, Nagle J, Polymeropoulos MH, Sturley SL, Ioannou YA, Higgins ME, Comly M, Cooney A, Brown A, Kaneski CR, Blanchette-Mackie EJ, Dwyer NK, Neufeld EB, Chang TY, Liscum L, Strauss JF 3rd, Ohno K, Zeigler M, Carmi R, Sokol J, Markie D, O&apos;Neill RR, van Diggelen OP, Elleder M, Patterson MC, Brady RO, Vanier MT, Pentchev PG, Tagle DA. Niemann\u2013Pick C1 disease gene: homology to mediators of cholesterol homeostasis. <i>Science<\/i>, <b>277<\/b>, 228\u2013231 (1997).","DOI":"10.1126\/science.277.5323.228"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Naureckiene S, Sleat DE, Lackland H, Fensom A, Vanier MT, Wattiaux R, Jadot M, Lobel P. Identification of HE1 as the second gene of Niemann\u2013Pick C disease. <i>Science<\/i>, <b>290<\/b>, 2298\u20132301 (2000).","DOI":"10.1126\/science.290.5500.2298"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Vanier MT. Niemann\u2013Pick disease type C. <i>Orphanet J. Rare Dis.<\/i>, <b>5<\/b>, 16 (2010).","DOI":"10.1186\/1750-1172-5-16"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Matsuo M, Togawa M, Hirabaru K, Mochinaga S, Narita A, Adachi M, Egashira M, Irie T, Ohno K. Effects of cyclodextrin in two patients with Niemann\u2013Pick Type C disease. <i>Mol. Genet. Metab.<\/i>, <b>108<\/b>, 76\u201381 (2013).","DOI":"10.1016\/j.ymgme.2012.11.005"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Higaki K, Ninomiya H, Sugimoto Y, Suzuki T, Taniguchi M, Niwa H, Pentchev PG, Vanier MT, Ohno K. Isolation of NPC1-deficient Chinese hamster ovary cell mutants by gene trap mutagenesis. <i>J. Biochem.<\/i>, <b>129<\/b>, 875\u2013880 (2001).","DOI":"10.1093\/oxfordjournals.jbchem.a002932"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Sugimoto Y, Ninomiya H, Ohsaki Y, Higaki K, Davies JP, Ioannou YA, Ohno K. Accumulation of cholera toxin and GM1 ganglioside in the early endosome of Niemann\u2013Pick C1-deficient cells. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>98<\/b>, 12391\u201312396 (2001).","DOI":"10.1073\/pnas.221181998"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Szente L, Szejtli J. Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in development. <i>Adv. Drug Deliv. Rev.<\/i>, <b>36<\/b>, 17\u201328 (1999).","DOI":"10.1016\/S0169-409X(98)00092-1"},{"key":"8","unstructured":"8) Uekama K, Otagiri M. Cyclodextrins in drug carrier systems. <i>Crit. Rev. Ther. Drug Carrier Syst.<\/i>, <b>3<\/b>, 1\u201340 (1987)."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Davidson CD, Ali NF, Micsenyi MC, Stephney G, Renault S, Dobrenis K, Ory DS, Vanier MT, Walkley SU. Chronic cyclodextrin treatment of murine Niemann\u2013Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression. <i>PLoS ONE<\/i>, <b>4<\/b>, e6951 (2009).","DOI":"10.1371\/journal.pone.0006951"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Liu B, Turley SD, Burns DK, Miller AM, Repa JJ, Dietschy JM. Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1\u2212\/\u2212 mouse. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>106<\/b>, 2377\u20132382 (2009).","DOI":"10.1073\/pnas.0810895106"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Porter FD, Scherrer DE, Lanier MH, Langmade SJ, Molugu V, Gale SE, Olzeski D, Sidhu R, Dietzen DJ, Fu R, Wassif CA, Yanjanin NM, Marso SP, House J, Vite C, Schaffer JE, Ory DS. Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann\u2013Pick C1 disease. <i>Sci. Transl. Med.<\/i>, <b>2<\/b>, 56ra81 (2010).","DOI":"10.1126\/scitranslmed.3001417"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Ward S, O\u2019Donnell P, Fernandez S, Vite CH. 2-Hydroxypropyl-\u03b2-cyclodextrin raises hearing threshold in normal cats and in cats with Niemann\u2013Pick type C disease. <i>Pediatr. Res.<\/i>, <b>68<\/b>, 52\u201356 (2010).","DOI":"10.1203\/PDR.0b013e3181df4623"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Soga M, Ishitsuka Y, Hamasaki M, Yoneda K, Furuya H, Matsuo M, Ihn H, Fusaki N, Nakamura K, Nakagata N, Endo F, Irie T, Era T. HPGCD outperforms HPBCD as a potential treatment for Niemann\u2013Pick disease type C during disease modeling with iPS cells. <i>Stem Cells<\/i>, <b>33<\/b>, 1075\u20131088 (2015).","DOI":"10.1002\/stem.1917"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Futaki S. Membrane permeable peptide vectors: chemistry and functional design for the therapeutic applications. <i>Adv. Drug Deliv. Rev.<\/i>, <b>60<\/b>, 447 (2008).","DOI":"10.1016\/j.addr.2007.11.001"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Nakase I, Akita H, Kogure K, Graslund A, Langel U, Harashima H, Futaki S. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides. <i>Acc. Chem. Res.<\/i>, <b>45<\/b>, 1132\u20131139 (2012).","DOI":"10.1021\/ar200256e"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Kaplan IM, Wadia JS, Dowdy SF. Cationic TAT peptide transduction domain enters cells by macropinocytosis. <i>J. Control. Release<\/i>, <b>102<\/b>, 247\u2013253 (2005).","DOI":"10.1016\/j.jconrel.2004.10.018"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Nakase I, Hirose H, Tanaka G, Tadokoro A, Kobayashi S, Takeuchi T, Futaki S. Cell-surface accumulation of flock house virus-derived peptide leads to efficient internalization <i>via<\/i> macropinocytosis. <i>Mol. Ther.<\/i>, <b>17<\/b>, 1868\u20131876 (2009).","DOI":"10.1038\/mt.2009.192"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Nakase I, Niwa M, Takeuchi T, Sonomura K, Kawabata N, Koike Y, Takehashi M, Tanaka S, Ueda K, Simpson JC, Jones AT, Sugiura Y, Futaki S. Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement. <i>Mol. Ther.<\/i>, <b>10<\/b>, 1011\u20131022 (2004).","DOI":"10.1016\/j.ymthe.2004.08.010"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Nakase I, Tadokoro A, Kawabata N, Takeuchi T, Katoh H, Hiramoto K, Negishi M, Nomizu M, Sugiura Y, Futaki S. Interaction of arginine-rich peptides with membrane-associated proteoglycans is crucial for induction of actin organization and macropinocytosis. <i>Biochemistry<\/i>, <b>46<\/b>, 492\u2013501 (2007).","DOI":"10.1021\/bi0612824"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Wadia JS, Stan RV, Dowdy SF. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. <i>Nat. Med.<\/i>, <b>10<\/b>, 310\u2013315 (2004).","DOI":"10.1038\/nm996"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Auz\u00e9ly-Velty R, Perly B, Tach\u00e9 O, Zemb T, J\u00e9han P, Guenot P, Dalbiez J-P, Djeda\u00efni-Pilard F. Cholesteryl-cyclodextrins: synthesis and insertion into phospholipid membranes. <i>Carbohydr. Res.<\/i>, <b>318<\/b>, 82\u201390 (1999).","DOI":"10.1016\/S0008-6215(99)00086-5"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Maeda Y, Motoyama K, Higashi T, Horikoshi Y, Takeo T, Nakagata N, Kurauchi Y, Katsuki H, Ishitsuka Y, Kondo Y, Irie T, Furuya H, Era T, Arima H. Effects of cyclodextrins on GM1-gangliosides in fibroblasts from GM1-gangliosidosis patients. <i>J. Pharm. Pharmacol.<\/i>, <b>67<\/b>, 1133\u20131142 (2015).","DOI":"10.1111\/jphp.12405"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Takechi-Haraya Y, Nadai R, Kimura H, Nishitsuji K, Uchimura K, Sakai-Kato K, Kawakami K, Shigenaga A, Kawakami T, Otaka A, Hojo H, Sakashita N, Saito H. Enthalpy-driven interactions with sulfated glycosaminoglycans promote cell membrane penetration of arginine peptides. <i>Biochim. Biophys. Acta<\/i>, <b>1858<\/b>, 1339\u20131349 (2016).","DOI":"10.1016\/j.bbamem.2016.03.021"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Rosenbaum AI, Maxfield FR. Niemann\u2013Pick type C disease: molecular mechanisms and potential therapeutic approaches. <i>J. Neurochem.<\/i>, <b>116<\/b>, 789\u2013795 (2011).","DOI":"10.1111\/j.1471-4159.2010.06976.x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Rosenbaum AI, Zhang G, Warren JD, Maxfield FR. Endocytosis of \u03b2-cyclodextrins is responsible for cholesterol reduction in Niemann\u2013Pick type C mutant cells. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>107<\/b>, 5477\u20135482 (2010).","DOI":"10.1073\/pnas.0914309107"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Elrick MJ, Yu T, Chung C, Lieberman AP. Impaired proteolysis underlies autophagic dysfunction in Niemann\u2013Pick type C disease. <i>Hum. Mol. Genet.<\/i>, <b>21<\/b>, 4876\u20134887 (2012).","DOI":"10.1093\/hmg\/dds324"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Ishibashi S, Yamazaki T, Okamoto K. Association of autophagy with cholesterol-accumulated compartments in Niemann\u2013Pick disease type C cells. <i>J. Clin. Neurosci.<\/i>, <b>16<\/b>, 954\u2013959 (2009).","DOI":"10.1016\/j.jocn.2008.09.020"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Ordonez MP, Roberts EA, Kidwell CU, Yuan SH, Plaisted WC, Goldstein LS. Disruption and therapeutic rescue of autophagy in a human neuronal model of Niemann\u2013Pick type C1. <i>Hum. Mol. Genet.<\/i>, <b>21<\/b>, 2651\u20132662 (2012).","DOI":"10.1093\/hmg\/dds090"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Sarkar S, Carroll B, Buganim Y, Maetzel D, Ng AH, Cassady JP, Cohen MA, Chakraborty S, Wang H, Spooner E, Ploegh H, Gsponer J, Korolchuk VI, Jaenisch R. Impaired autophagy in the lipid-storage disorder Niemann\u2013Pick type C1 disease. <i>Cell Reports<\/i>, <b>5<\/b>, 1302\u20131315 (2013).","DOI":"10.1016\/j.celrep.2013.10.042"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Lieberman AP, Puertollano R, Raben N, Slaugenhaupt S, Walkley SU, Ballabio A. Autophagy in lysosomal storage disorders. <i>Autophagy<\/i>, <b>8<\/b>, 719\u2013730 (2012).","DOI":"10.4161\/auto.19469"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Nixon RA. The role of autophagy in neurodegenerative disease. <i>Nat. Med.<\/i>, <b>19<\/b>, 983\u2013997 (2013).","DOI":"10.1038\/nm.3232"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Tamura A, Yui N. \u03b2-Cyclodextrin-threaded biocleavable polyrotaxanes ameliorate impaired autophagic flux in Niemann\u2013Pick type C disease. <i>J. Biol. Chem.<\/i>, <b>290<\/b>, 9442\u20139454 (2015).","DOI":"10.1074\/jbc.M115.636803"}],"container-title":["Biological &amp; Pharmaceutical Bulletin","Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/39\/11\/39_b16-00369\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T22:02:37Z","timestamp":1498341757000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/39\/11\/39_b16-00369\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b16-00369","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}